According to DKA 'The barriers to entry in the AI Healthcare industry are lower than for AI in drug discovery and these companies can achieve real results with much less funding and fewer highly specialized employees.' AI for Drug Discovery companies need much higher levels of expertise in traditional biopharmaceutical science (biochemistry, biology, biomedicine, etc.) and in core AI techniques
Progress is tracked inside the app over time
1 2 "Living With Pernicious Anemia"
Mild increases in serum aspartate transaminase, alanine transaminase, lactate dehydrogenase, bilirubin, and alkaline phosphatase may be seen
By inhibiting the enzyme, the Merck scientists aimed to prolong the beneficial effects of GLP-1 (figure 35)
Each compound targets a specific aspect of cellular energy metabolism sirtuin activation and mitochondrial biogenesis (NAD+) or antioxidant defense and detoxification (glutathione)